Oct 18, 2026 08:00PM
Aug 6, 2026 07:01AM
Aug 6, 2026 07:00AM
Aug 3, 2026 09:00AM
Jun 23, 2026 07:00AM
Jun 23, 2026 07:00AM
May 7, 2026 07:00AM Amylyx Pharmaceuticals, Inc. (AMLX) Misses Q1 EPS by 4c
May 7, 2026 07:00AM
Apr 30, 2026 09:00AM
Mar 3, 2026 07:00AM
Mar 3, 2026 07:00AM
Feb 24, 2026 09:00AM
Dec 5, 2025 09:00AM
Dec 5, 2025 09:00AM Amylyx Pharmaceuticals Announces New Safety and Tolerability Cohort 1 Data of AMX0114 in ALS from First-in-Human LUMINA Trial
Nov 6, 2025 07:03AM
Nov 6, 2025 07:00AM
Oct 30, 2025 09:00AM
Oct 17, 2025 08:35AM
Oct 10, 2025 11:08AM
Oct 7, 2025 03:12PM
Aug 7, 2025 07:00AM Amylyx Pharmaceuticals, Inc. (AMLX) Reports In-Line Q2 EPS
Aug 7, 2025 07:00AM
Jul 31, 2025 09:00AM
Jul 13, 2025 05:00PM
Jul 8, 2025 07:00AM
Jun 3, 2025 07:01AM
Jun 3, 2025 07:00AM
May 12, 2025 07:01AM Amylyx Pharmaceuticals (AMLX) Announces Positive Long-Term Results from Phase 2 HELIOS Trial of AMX0035
May 12, 2025 07:00AM
May 8, 2025 07:01AM
May 8, 2025 07:00AM
May 1, 2025 09:00AM
Apr 30, 2025 07:03AM
Apr 30, 2025 07:00AM
Apr 9, 2025 07:00AM Amylyx Pharmaceuticals Announces First Participant Dosed in Phase 1, Multiple Ascending Dose LUMINA Trial of AMX0114 in People Living with Amyotrophic Lateral Sclerosis
Mar 4, 2025 06:00AM
Mar 4, 2025 06:00AM
Feb 24, 2025 09:00AM
Jan 21, 2025 09:00AM
Jan 21, 2025 09:00AM
Jan 6, 2025 09:00AM
Dec 4, 2024 07:32AM Amylyx Pharmaceuticals (AMLX) Announces Pivotal Phase 3 LUCIDITY Trial Design for Avexitide
Dec 4, 2024 07:30AM
Nov 7, 2024 07:02AM
Nov 7, 2024 07:00AM
Nov 4, 2024 09:00AM
Aug 12, 2024 09:00AM
Aug 8, 2024 07:00AM
Aug 8, 2024 07:00AM Amylyx Pharmaceuticals Reports Second Quarter 2024 Financial Results
Aug 5, 2024 09:00AM

1,232,681 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All